Drugs / CD19-IL7Ra CAR-T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07078929 | Jan → Sep 2026 overdue | B-cell acute lymphoblastic leukemia, childhood acute lymphoblastic leukemia | Chulalongkorn University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD19-IL7Ra CAR-T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07078929 ↗ |
| Modality | Cell therapy | “Chimeric antigen receptor T cell” NCT07078929 ↗ |
| Route | Other | “administered via central venous access catheter” NCT07078929 ↗ |